Comparing two bladder surgeries for urinary control in women with bladder cancer
Compares two bladder removal surgeries with a new bladder, in women with bladder cancer.
Plain-language title generated from the registry record
Registry title: Urinary Continence of Female POPRC and OIN
Key facts
- Where
- Guangzhou, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 55 and 75 years old?
Source: NCT05325216, who can take part
Where in China
- Sun Yat-sen Memorial HospitalGuangzhou, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Trial code
- NCT05325216
- Record updated
- 13 April 2022
- Original description
To compare the urinary continence rate and long-term oncological outcomes of pelvic-organ preserving radical cystectomy (POPRC) with orthotopic ileal neobladder (OIN) versus standard radical cystectomy(SRC) with OIN.Read full original descriptionShow less
Urinary Continence of Female Pelvic Organ-preserving Radical Cystectomy and Orthotopic Ileal Neobladder: A Randomized Controlled Study
To compare the urinary continence rate and long-term oncological outcomes of pelvic-organ preserving radical cystectomy (POPRC) with orthotopic ileal neobladder (OIN) versus standard radical cystectomy(SRC) with OIN.
Inclusion: Female patients aged between 55-75; Patients those who are diagnosed with organ-confined urothelial carcinoma（<pT3）; Patients those who are capable for radical cystectomy with orthotopic ileal neobladder; ECOG score between 0-2; Normal renal function; Patients those who volunteer to participate in this study and sign the informed consents; Patients those who are able to cooperate in the study.
Exclusion: Patients thsoe who are diagnosed distant metastasis before surgery; Patients those who had received pelvic radiotherapy or major pelvic operation; Previous history of malignancy of pelvic organs or surgical resection of pelvic organs; Patients those who are diagnosed with other malignancies; Any other conditions that the researcher considers to be excluded from this study; Absence of tumour in bladder neck or urethra; Pregnancy status.